Ferreira J, Linares-Loyez J, Bon P, Cognet L, Groc L
STAR Protoc. 2025; 6(1):103639.
PMID: 39998951
PMC: 11903812.
DOI: 10.1016/j.xpro.2025.103639.
Ferreira J, Disserol C, de Freitas Dias B, Marques A, Cardoso M, Silva P
Arq Neuropsiquiatr. 2024; 82(12):1-13.
PMID: 39706227
PMC: 11661894.
DOI: 10.1055/s-0044-1793933.
Wang H, Xie C, Deng B, Ding J, Li N, Kou Z
Nat Struct Mol Biol. 2024; 31(12):1987-1996.
PMID: 39227720
PMC: 11638077.
DOI: 10.1038/s41594-024-01387-3.
Zhao M, Lynch D, Irani S
Brain. 2024; 147(8):2601-2603.
PMID: 39073761
PMC: 11292893.
DOI: 10.1093/brain/awae236.
Fukata Y, Fukata M, MacGillavry H, Nair D, Hosy E
J Neurosci. 2024; 44(23).
PMID: 38839340
PMC: 11154862.
DOI: 10.1523/JNEUROSCI.2104-23.2024.
Positive Allosteric Modulation of NMDARs Prevents the Altered Surface Dynamics Caused by Patients' Antibodies.
Maudes E, Jamet Z, Marmolejo L, Dalmau J, Groc L
Neurol Neuroimmunol Neuroinflamm. 2024; 11(4):e200261.
PMID: 38771989
PMC: 11111324.
DOI: 10.1212/NXI.0000000000200261.
NMDA receptor autoantibodies primarily impair the extrasynaptic compartment.
Jamet Z, Mergaux C, Meras M, Bouchet D, Villega F, Kreye J
Brain. 2024; 147(8):2745-2760.
PMID: 38758090
PMC: 11292910.
DOI: 10.1093/brain/awae163.
Prophylactic treatment with the c-Abl inhibitor, neurotinib, diminishes neuronal damage and the convulsive state in pilocarpine-induced mice.
Chandia-Cristi A, Gutierrez D, Dulcey A, Lara M, Vargas L, Lin Y
Cell Rep. 2024; 43(5):114144.
PMID: 38656874
PMC: 11230136.
DOI: 10.1016/j.celrep.2024.114144.
Nanoscale Reorganization of Glutamate Receptors Underlies Synaptic Plasticity and Pathology.
Chen J, Tang A
Neurosci Bull. 2024; 40(6):840-844.
PMID: 38372930
PMC: 11178730.
DOI: 10.1007/s12264-024-01180-8.
Converging synaptic and network dysfunctions in distinct autoimmune encephalitis.
Hunter D, Petit-Pedrol M, Fernandes D, Benac N, Rodrigues C, Kreye J
EMBO Rep. 2024; 25(3):1623-1649.
PMID: 38253690
PMC: 10933378.
DOI: 10.1038/s44319-024-00056-2.
Anti-NMDA and Anti-AMPA Receptor Antibodies in Central Disorders: Preclinical Approaches to Assess Their Pathological Role and Translatability to Clinic.
Olivero G, Roggeri A, Pittaluga A
Int J Mol Sci. 2023; 24(19).
PMID: 37834353
PMC: 10573896.
DOI: 10.3390/ijms241914905.
N-methyl-D-aspartate receptor hypofunction as a potential contributor to the progression and manifestation of many neurological disorders.
Dong B, Yue Y, Dong H, Wang Y
Front Mol Neurosci. 2023; 16:1174738.
PMID: 37396784
PMC: 10308130.
DOI: 10.3389/fnmol.2023.1174738.
Deficits in integrative NMDA receptors caused by Grin1 disruption can be rescued in adulthood.
Venkatesan S, Binko M, Mielnik C, Ramsey A, Lambe E
Neuropsychopharmacology. 2023; 48(12):1742-1751.
PMID: 37349472
PMC: 10579298.
DOI: 10.1038/s41386-023-01619-y.
Long-term α5 GABA A receptor negative allosteric modulator treatment reduces NMDAR-mediated neuronal excitation and maintains basal neuronal inhibition.
Nuwer J, Povysheva N, Jacob T
Neuropharmacology. 2023; 237:109587.
PMID: 37270156
PMC: 10527172.
DOI: 10.1016/j.neuropharm.2023.109587.
Autoimmune encephalitis: recent clinical and biological advances.
Varley J, Strippel C, Handel A, Irani S
J Neurol. 2023; 270(8):4118-4131.
PMID: 37115360
PMC: 10345035.
DOI: 10.1007/s00415-023-11685-3.
Single-cell transcriptomics reveals cell type-specific immune regulation associated with anti-NMDA receptor encephalitis in humans.
Jiang Y, Dai S, Jia L, Qin L, Zhang M, Liu H
Front Immunol. 2022; 13:1075675.
PMID: 36544777
PMC: 9762154.
DOI: 10.3389/fimmu.2022.1075675.
Targeting NMDA Receptor Complex in Management of Epilepsy.
Sivakumar S, Ghasemi M, Schachter S
Pharmaceuticals (Basel). 2022; 15(10).
PMID: 36297409
PMC: 9609646.
DOI: 10.3390/ph15101297.
NMDAR autoantibodies in psychiatric disease - An immunopsychiatric continuum and potential predisposition for disease pathogenesis.
Hansen N
J Transl Autoimmun. 2022; 5:100165.
PMID: 36176328
PMC: 9513762.
DOI: 10.1016/j.jtauto.2022.100165.
Targeting NMDA Receptors at the Neurovascular Unit: Past and Future Treatments for Central Nervous System Diseases.
Seillier C, Lesept F, Toutirais O, Potzeha F, Blanc M, Vivien D
Int J Mol Sci. 2022; 23(18).
PMID: 36142247
PMC: 9499580.
DOI: 10.3390/ijms231810336.
Regulation of NMDA Receptor Signaling at Single Synapses by Human Anti-NMDA Receptor Antibodies.
Dean C, Metzbower S, Dessain S, Blanpied T, Benavides D
Front Mol Neurosci. 2022; 15:940005.
PMID: 35966009
PMC: 9371948.
DOI: 10.3389/fnmol.2022.940005.